Malignant pleural mesothelioma (MM) is a highly aggressive tumor characterized by a poor
prognosis. Although its carcinogenesis mechanism has not been strictly understood, about …

Background: New tumour biomarkers are being intensely investigated for malignant
mesothelioma (MM). Fibulin-3 is produced in MM but its role remains uncertain. The aim of …

Background Soluble mesothelin is beneficial to detect the progression and the treatment
response of malignant pleural mesothelioma. However, the prognostic value of soluble …

Özet Amaç: Malign plevral mezotelyoma (MPM) Türkiye için önemli bir halk sağlığı
sorunudur. MPM yönetiminde Türkiye kliniklerinde ortak bir zemin oluşturmak amacıyla …

Background It is a great challenge for pathologists to initially diagnose metastatic malignant
mesothelioma (MM) by the lymph node biopsy without any history of primary MM. Because …

This guideline was prepared for forming a “standards guideline” that would be used by
clinics in Turkey for the epidemiological evaluation, clinical diagnosis, and treatment of …

Overview Malignant pleural mesothelioma is an aggressive malignancy with an incidence
that may be peaking worldwide in the next 5–10 years. While the majority of patients do …

Al Manhal Platform The session has been expired. Please reload the page Reload Please
wait... The file is being prepared Preview Mode If you would like full access to this publication …